High-efficacy disease-modifying therapies despite clinical stability: the role of patients on treatment decisions (PERCEPTIONS-MS Study)

被引：0
|
作者：
Saposnik, G. [1 ,2 ,3 ]
Sempere, A. P. [4 ]
Aladro-Benito, Y. [5 ]
Sotoca, J. [6 ]
Bakdache, F. [7 ]
Terzaghi, M. [2 ,8 ]
Maurino, J. [9 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Dept Med, Div Neurol, Toronto, ON, Canada
[2] St Michaels Hosp, Decis Neurosci Unit, Toronto, ON, Canada
[3] Univ Zurich, Lab Social & Neural Syst Res, Dept Econ, Zurich, Switzerland
[4] Hosp Gen Univ Alicante, Dept Neurol, Alicante, Spain
[5] Hosp Univ Getafe, Dept Neurol, Getafe, Spain
[6] Hosp Univ Mutua Terrassa, Dept Neurol, Terrassa, Spain
[7] Hoffmann La Roche Ltd, Neurosci, Med Affairs, Mississauga, ON, Canada
[8] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[9] Roche Farma SA, Med Dept, Madrid, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1433
引用
收藏
页码：800 / 800
页数：1
相关论文
共 50 条
  • [1] High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions
    Jorge Maurino
    Javier Sotoca
    Ángel P. Sempere
    Luis Brieva
    Carlos López de Silanes
    Ana B. Caminero
    María Terzaghi
    Julia Gracia-Gil
    Gustavo Saposnik
    The Patient - Patient-Centered Outcomes Research, 2021, 14 : 241 - 248
  • [2] High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions
    Maurino, Jorge
    Sotoca, Javier
    Sempere, Angel P.
    Brieva, Luis
    Lopez de Silanes, Carlos
    Caminero, Ana B.
    Terzaghi, Maria
    Gracia-Gil, Julia
    Saposnik, Gustavo
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (02): : 241 - 248
  • [3] The impact of high-efficacy disease-modifying therapies in cognitive impairment in Multiple Sclerosis patients
    Rodriguez, F.
    Sainz de la Maza, S.
    Chico, J.
    Sainz, R.
    Walo-Delgado, P.
    Villar, L.
    Costa-Frossard, L.
    Masjuan, J.
    Monreal, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 464 - 464
  • [4] Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches
    Grand'Maison, Francois
    Yeung, Michael
    Morrow, Sarah A.
    Lee, Liesly
    Emond, Francois
    Ward, Brian J.
    Laneuville, Pierre
    Schecter, Robyn
    NEURAL REGENERATION RESEARCH, 2018, 13 (11) : 1871 - 1874
  • [5] Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches
    Francois Grand'Maison
    Michael Yeung
    Sarah A.Morrow
    Liesly Lee
    Francois Emond
    Brian J.Ward
    Pierre Laneuville
    Robyn Schecter
    Neural Regeneration Research, 2018, 13 (11) : 1871 - 1874
  • [6] Defining the profiles of patients who receive high-efficacy disease-modifying therapies for multiple sclerosis in real clinical practice
    Gifreu-Fraixino, Ariadna
    Boix-Lago, Almudena
    Alvarez-Bravo, Gary
    Miguela-Benavides, Albert
    Huertas-Pons, Joana M.
    Quiroga-Varela, Ana
    Coll-Martinez, Claudia
    Ramio-Torrenta, Lluis
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1094 - 1095
  • [7] Wearing-Off Effect Toward the End of Treatment Cycles in Patients With MS Receiving High-Efficacy Disease-Modifying Therapies: Data From Social Media Listening
    Clement, Ivan John
    Fielding, Joanne
    Serceau, Marie
    Robinson, Janine
    Deshpande, Chinmay
    NEUROLOGY, 2023, 100 (17)
  • [8] Paradigm shifts: Early initiation of high-efficacy disease-modifying treatment in multiple sclerosis
    Hartung, Hans-Peter
    Meuth, Sven G.
    Thompson, Alan J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (10) : 1473 - 1476
  • [9] Initial high-efficacy disease-modifying therapy in multiple sclerosis A nationwide cohort study
    Buron, Mathias Due
    Chalmer, Thor Ameri
    Sellebjerg, Finn
    Barzinji, Ismael
    Christensen, Jeppe Romme
    Christensen, Mette Kirstine
    Hansen, Victoria
    Illes, Zsolt
    Jensen, Henrik Boye
    Kant, Matthias
    Papp, Viktoria
    Petersen, Thor
    Rasmussen, Peter Vestergaard
    Schafer, Jakob
    Theodorsdottir, Asta
    Weglewski, Arkadiusz
    Sorensen, Per Soelberg
    Magyari, Melinda
    NEUROLOGY, 2020, 95 (08) : E1041 - E1051
  • [10] Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies
    Bridge, Francesca
    Brotherton, Julia
    Stankovich, Jim
    Sanfilippo, Paul G.
    Skibina, Olga G.
    Buzzard, Katherine
    Kalincik, Tomas
    Nguyen, Ai-Lan
    Guo, Kylie
    Monif, Mastura
    Wrede, C. David
    Rath, Louise
    Taylor, Lisa
    Butzkueven, Helmut
    Jokubaitis, Vilija G.
    van der Walt, Anneke
    NEUROLOGY, 2024, 102 (04) : 1 - 13
12345